These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1449366)

  • 1. [Exogenous surfactants. Indications and limits in 1992].
    Voyer M; Laudat F; Kochert F; Zeller J
    Arch Fr Pediatr; 1992 Apr; 49 Suppl 1():237-9. PubMed ID: 1449366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Exogenous surfactants in neonatology].
    Zupan V; Meric M; Dehan M
    Rev Mal Respir; 1995; 12(6):642-5. PubMed ID: 8677364
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F; Dehan M; de Fontanges A; Lindenbaum A; Perret L; Puisieux F
    Arch Fr Pediatr; 1985 May; 42(5):397-402. PubMed ID: 3907577
    [No Abstract]   [Full Text] [Related]  

  • 4. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ; Chen C; Jin QL; Shao XM
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exogenous surfactants of natural origin. What is new in 1992?].
    Walti H; Breart G; Relier JP
    Arch Fr Pediatr; 1992 Apr; 49 Suppl 1():231-2. PubMed ID: 1449364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lung morphological changes in premature neonates with hyaline membrane disease due to the use of exogenous surfactants during mechanical ventilation].
    Golubev AM; Perepelitsa SA; Smerdova EF; Moroz VV
    Arkh Patol; 2010; 72(6):34-8. PubMed ID: 21400780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Exogenous surfactants in infants. Indications and limitations].
    Voyer M; Magny JF
    Presse Med; 1993 Feb; 22(5):194-6. PubMed ID: 8511131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Artificial exogenous surfactants].
    Hascoët JM; Claris O
    Arch Fr Pediatr; 1992 Apr; 49 Suppl 1():233-6. PubMed ID: 1449365
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary surfactant replacement in respiratory distress syndrome.
    Vidyasagar D; Shimada S
    Clin Perinatol; 1987 Dec; 14(4):991-1015. PubMed ID: 3322633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
    Ji SP; Zhang XL; Ma WX; Sun YP; Li XH; Yu JH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):248. PubMed ID: 17448287
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giving surfactant to premature infants.
    Ioli JG; Richardson MJ
    Am J Nurs; 1990 Mar; 90(3):59-60. PubMed ID: 2178422
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary surfactant and its clinical application.
    Jin HZ
    Chin Med J (Engl); 1991 Mar; 104(3):225-7. PubMed ID: 2065535
    [No Abstract]   [Full Text] [Related]  

  • 15. Newer strategies in the prevention of hyaline membrane disease.
    Willett LD
    Nebr Med J; 1994 Aug; 79(8):303-4. PubMed ID: 7990997
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)].
    Göcke H; Bienengräber A
    Zentralbl Chir; 1974 Aug; 99(34):1057-61. PubMed ID: 4613061
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA; Metcalfe IL; Duffty P; Possmayer F; Bryan MH; Enhorning G
    Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exogenous surfactants].
    Dehan M; Denizot B
    Arch Fr Pediatr; 1989 Feb; 46(2):85-7. PubMed ID: 2660764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapy of respiratory distress syndrome in the newborn infant].
    Stannigel H
    Gynakologe; 1992 Jun; 25(3):164-8. PubMed ID: 1505797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.